drugset / Trial / NCT00823199
An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
This is a four week open label trial of ALLOPURINOL to the treatment regime of ten (10) poorly responsive patients with schizophrenia, monitoring their response and side-effects. No change in medication is required.
Timeline
- Start
- 2005-11
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopurinol | Small molecule | 300 mg | Oral |